Armistice Capital, LLC 13D and 13G filings for Acurx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:39 pm Sale |
2023-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP |
Armistice Capital, LLC | 723,104 4.990% |
-156,896 (-17.83%) |
Filing |
| 2023-02-14 11:52 am Purchase |
2022-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP |
Armistice Capital, LLC | 880,000 7.590% |
880,000 (New Position) |
Filing |